Drawing for BREPLAZO

USPTO serial 85031923

BREPLAZO

Reviewed by CopyMark Law Group

Reg. 3972991Status 710
Filing date
Status date
Registration date
Jun 7, 2011
Examiner
BENJAMIN, SARA NICOLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BREPLAZO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

Christopher M. Hanes GlaxoSmithKlineFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 12, 2018C8..CANCELLED SEC. 8 (6-YR)—
Jun 7, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 22, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 20, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 15, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 7, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 22, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 22, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 17, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Feb 11, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 11, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 11, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 1, 2011DMCCDATA MODIFICATION COMPLETED—
Feb 1, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 1, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2011ALIEASSIGNED TO LIE—
Jan 17, 2011ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 9, 2010GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 9, 2010GNSLLETTER OF SUSPENSION E-MAILED—
Aug 9, 2010CNSLSUSPENSION LETTER WRITTEN—
Aug 9, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Aug 9, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 9, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 9, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 6, 2010DOCKASSIGNED TO EXAMINER—
May 12, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance